The stock has a 36-month beta value of 2.29. Opinions on the stock are mixed, with 6 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for CRGX is 31.96M, and at present, short sellers hold a 17.43% of that float. On November 15, 2024, the average trading volume of CRGX was 304.43K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CRGX) stock’s latest price update
CARGO Therapeutics Inc (NASDAQ: CRGX)’s stock price has gone decline by -10.67 in comparison to its previous close of 19.03, however, the company has experienced a -20.89% decrease in its stock price over the last five trading days. globenewswire.com reported 2024-11-05 that SAN CARLOS, Calif., Nov. 05, 2024 (GLOBE NEWSWIRE) — CARGO Therapeutics, Inc.
CRGX’s Market Performance
CARGO Therapeutics Inc (CRGX) has seen a -20.89% fall in stock performance for the week, with a -26.18% decline in the past month and a 2.60% surge in the past quarter. The volatility ratio for the week is 11.80%, and the volatility levels for the past 30 days are at 7.81% for CRGX. The simple moving average for the past 20 days is -18.68% for CRGX’s stock, with a -15.33% simple moving average for the past 200 days.
Analysts’ Opinion of CRGX
Many brokerage firms have already submitted their reports for CRGX stocks, with H.C. Wainwright repeating the rating for CRGX by listing it as a “Buy.” The predicted price for CRGX in the upcoming period, according to H.C. Wainwright is $33 based on the research report published on July 22, 2024 of the current year 2024.
Chardan Capital Markets, on the other hand, stated in their research note that they expect to see CRGX reach a price target of $28. The rating they have provided for CRGX stocks is “Buy” according to the report published on July 08th, 2024.
Piper Sandler gave a rating of “Overweight” to CRGX, setting the target price at $37 in the report published on June 27th of the current year.
CRGX Trading at -17.67% from the 50-Day Moving Average
After a stumble in the market that brought CRGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -49.88% of loss for the given period.
Volatility was left at 7.81%, however, over the last 30 days, the volatility rate increased by 11.80%, as shares sank -21.66% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.50% lower at present.
During the last 5 trading sessions, CRGX fell by -20.89%, which changed the moving average for the period of 200-days by -22.76% in comparison to the 20-day moving average, which settled at $20.91. In addition, CARGO Therapeutics Inc saw -26.57% in overturn over a single year, with a tendency to cut further losses.
Insider Trading
Reports are indicating that there were more than several insider trading activities at CRGX starting from Chapman Gina, who sale 7,166 shares at the price of $25.09 back on Sep 18 ’24. After this action, Chapman Gina now owns 103,905 shares of CARGO Therapeutics Inc, valued at $179,775 using the latest closing price.
Chapman Gina, the President & CEO of CARGO Therapeutics Inc, sale 2,975 shares at $25.03 during a trade that took place back on Sep 19 ’24, which means that Chapman Gina is holding 103,905 shares at $74,457 based on the most recent closing price.
Stock Fundamentals for CRGX
The total capital return value is set at -0.4. Equity return is now at value -69.81, with -57.80 for asset returns.
Based on CARGO Therapeutics Inc (CRGX), the company’s capital structure generated 0.07 points at debt to capital in total, while cash flow to debt ratio is standing at -4.68.
Currently, EBITDA for the company is -93.02 million with net debt to EBITDA at 0.26. The liquidity ratio also appears to be rather interesting for investors as it stands at 18.95.
Conclusion
To sum up, CARGO Therapeutics Inc (CRGX) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
